Clinical Trial Innovation

N.1 maintains a clinical/translational team that facilitates IRB/DSRB filings and assists with regulatory considerations with a particular focus on interventional studies. The Institute also maintains an advisory team of clinicians, engineers, and industry leaders to address Institute objectives ranging from clinical acceleration to compliance.